These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6785973)

  • 1. 'Early' splenectomy and survival in agnogenic myeloid metaplasia. An analysis of 338 cases published since 1940.
    Benbassat J; Penchas S
    Acta Haematol; 1981; 65(3):189-92. PubMed ID: 6785973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases.
    Benbassat J; Penchas S; Ligumski M
    Br J Haematol; 1979 Jun; 42(2):207-14. PubMed ID: 465366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex and splenectomy in agnogenic myeloid metaplasia.
    Benbassat J; Penchas S
    Acta Haematol; 1980; 64(2):114-6. PubMed ID: 6776767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy in myeloid metaplasia.
    Silverstein MN; ReMine WH
    Blood; 1979 Mar; 53(3):515-8. PubMed ID: 760865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia.
    Brenner B; Tavori S; Tatarsky I
    Haemostasis; 1987; 17(3):141-6. PubMed ID: 3609915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia.
    Benbassat J; Gilon D; Penchas S
    Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with splenectomy in auto-immune thrombocytopenia and agnogenic myeloid metaplasia.
    Heaton A; Jacobs P; Dent DM; Louw JH
    S Afr Med J; 1976 Sep; 50(39):1506-12. PubMed ID: 988641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy for agnogenic myeloid metaplasia.
    Gomes MR; Silverstein MN; Remine WH
    Surg Gynecol Obstet; 1967 Jul; 125(1):106-8. PubMed ID: 6026679
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenectomy in agnogenic myeloid metaplasia.
    Porcu P; Neiman RS; Orazi A
    Blood; 1999 Mar; 93(6):2132-4. PubMed ID: 10189205
    [No Abstract]   [Full Text] [Related]  

  • 12. Splenectomy in agnogenic myeloid metaplasia: factors of possible prognostic significance.
    Penchas S; Steinwel A; Sukenik S; Benbassat J
    Postgrad Med J; 1982 Apr; 58(678):212-5. PubMed ID: 7111100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agnogenic myeloid metaplasia: role of splenectomy.
    Marks C; Ahmadi M
    Postgrad Med J; 1969 Apr; 45(522):261-5. PubMed ID: 5821186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic parameters in myeloid metaplasia: agnogenic versus postpolycythemic.
    Meytes D; Katz D; Ramot B
    Isr J Med Sci; 1976 Jun; 12(6):534-42. PubMed ID: 955869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
    Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
    Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe post-splenectomy hepatic insufficiency in a patient with agnogenic myeloid metaplasia].
    Pérez-Villa F; Font J; Feliu E; Campo E; Ingelmo M
    Med Clin (Barc); 1988 Jun; 91(3):108-10. PubMed ID: 3172909
    [No Abstract]   [Full Text] [Related]  

  • 17. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
    Akpek G; McAneny D; Weintraub L
    J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agnogenic myeloid metaplasia; its current managment.
    Silverstein MN
    Minn Med; 1970 Mar; 53(3):257-9. PubMed ID: 5415744
    [No Abstract]   [Full Text] [Related]  

  • 20. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
    Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
    Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.